NYSE:HYH - Halyard Health Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$53.79 +0.10 (+0.19 %)
(As of 05/24/2018 03:55 AM ET)
Previous Close$53.69
Today's Range$52.62 - $53.84
52-Week Range$35.79 - $54.46
Volume241,200 shs
Average Volume406,757 shs
Market Capitalization$2.54 billion
P/E Ratio22.89
Dividend YieldN/A
Beta1.62

About Halyard Health (NYSE:HYH)

Halyard Health logoHalyard Health, Inc. operates as a medical technology company that focuses on eliminating pain, speeding recovery, and preventing infection for healthcare providers and patients worldwide. Its Medical Devices segment provides a portfolio of products that focuses on respiratory and digestive health, along with surgical and interventional pain management. Its products include post-operative pain management solutions, minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes. This segment sells its products under the ON-Q, COOLIEF, MICROCUFF, MIC-KEY, HOMEPUMP, CORTRAK, and other brand names. The company markets its products directly to hospitals and other healthcare providers, as well as through third-party distribution channels. Halyard Health, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Receive HYH News and Ratings via Email

Sign-up to receive the latest news and ratings for HYH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
SymbolNYSE:HYH
CUSIPN/A
Phone678-425-9273

Debt

Debt-to-Equity Ratio0.43
Current Ratio3.22
Quick Ratio2.96

Price-To-Earnings

Trailing P/E Ratio22.89
Forward P/E Ratio30.39
P/E Growth3.44

Sales & Book Value

Annual Sales$611.60 million
Price / Sales4.14
Cash Flow$1.2374 per share
Price / Cash43.47
Book Value$26.63 per share
Price / Book2.02

Profitability

EPS (Most Recent Fiscal Year)$2.35
Net Income$79.30 million
Net Margins7.72%
Return on Equity7.90%
Return on Assets4.38%

Miscellaneous

Employees13,000
Outstanding Shares47,020,000

Halyard Health (NYSE:HYH) Frequently Asked Questions

What is Halyard Health's stock symbol?

Halyard Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "HYH."

How were Halyard Health's earnings last quarter?

Halyard Health (NYSE:HYH) posted its quarterly earnings data on Wednesday, May, 2nd. The medical instruments supplier reported $0.76 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.17 by $0.59. The medical instruments supplier earned $156.40 million during the quarter, compared to analysts' expectations of $155.08 million. Halyard Health had a net margin of 7.72% and a return on equity of 7.90%. The firm's quarterly revenue was up 7.3% on a year-over-year basis. During the same quarter last year, the company posted $0.48 EPS. View Halyard Health's Earnings History.

What guidance has Halyard Health issued on next quarter's earnings?

Halyard Health updated its FY18 earnings guidance on Wednesday, May, 2nd. The company provided EPS guidance of $1.65-$1.85 for the period, compared to the Thomson Reuters consensus estimate of $1.26.

What price target have analysts set for HYH?

5 equities research analysts have issued 1 year target prices for Halyard Health's stock. Their predictions range from $50.00 to $62.00. On average, they anticipate Halyard Health's share price to reach $55.50 in the next twelve months. View Analyst Ratings for Halyard Health.

Who are some of Halyard Health's key competitors?

Who are Halyard Health's key executives?

Halyard Health's management team includes the folowing people:
  • Mr. Steven E. Voskuil, Sr. VP & CFO (Age 50)
  • Mr. John W. Wesley, Sr. VP & Gen. Counsel (Age 59)
  • Ms. Rhonda D. Gibby, Sr. VP & Chief HR Officer (Age 50)
  • Mr. Joseph F. Woody, CEO & Director (Age 52)
  • Mr. Renato Negro, VP, Controller & Chief Accounting Officer

Has Halyard Health been receiving favorable news coverage?

Media headlines about HYH stock have been trending somewhat positive this week, according to Accern Sentiment. The research group identifies negative and positive media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Halyard Health earned a media sentiment score of 0.13 on Accern's scale. They also assigned media stories about the medical instruments supplier an impact score of 47.20 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near term.

Who are Halyard Health's major shareholders?

Halyard Health's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (10.62%), Dimensional Fund Advisors LP (7.28%), Paradice Investment Management LLC (3.30%), Northern Trust Corp (3.23%), Champlain Investment Partners LLC (1.60%) and Prudential Financial Inc. (1.03%). View Institutional Ownership Trends for Halyard Health.

Which major investors are selling Halyard Health stock?

HYH stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Prudential Financial Inc., Chicago Equity Partners LLC, Schwab Charles Investment Management Inc., Wells Fargo & Company MN, Spark Investment Management LLC, Citigroup Inc. and Russell Investments Group Ltd.. View Insider Buying and Selling for Halyard Health.

Which major investors are buying Halyard Health stock?

HYH stock was acquired by a variety of institutional investors in the last quarter, including Champlain Investment Partners LLC, Select Equity Group L.P., Great West Life Assurance Co. Can, New York State Common Retirement Fund, Lord Abbett & CO. LLC, Millennium Management LLC, BlackRock Inc. and Great Lakes Advisors LLC. View Insider Buying and Selling for Halyard Health.

How do I buy shares of Halyard Health?

Shares of HYH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Halyard Health's stock price today?

One share of HYH stock can currently be purchased for approximately $53.79.

How big of a company is Halyard Health?

Halyard Health has a market capitalization of $2.54 billion and generates $611.60 million in revenue each year. The medical instruments supplier earns $79.30 million in net income (profit) each year or $2.35 on an earnings per share basis. Halyard Health employs 13,000 workers across the globe.

How can I contact Halyard Health?

Halyard Health's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The medical instruments supplier can be reached via phone at 678-425-9273 or via email at [email protected]


MarketBeat Community Rating for Halyard Health (HYH)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  183 (Vote Outperform)
Underperform Votes:  192 (Vote Underperform)
Total Votes:  375
MarketBeat's community ratings are surveys of what our community members think about Halyard Health and other stocks. Vote "Outperform" if you believe HYH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HYH will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Halyard Health (NYSE:HYH) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Halyard Health in the last 12 months. Their average twelve-month price target is $55.50, suggesting that the stock has a possible upside of 3.18%. The high price target for HYH is $62.00 and the low price target for HYH is $50.00. There are currently 1 sell rating and 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.603.002.752.60
Ratings Breakdown: 1 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $55.50$47.00$47.00$44.00
Price Target Upside: 3.18% upside3.41% upside0.70% downside7.04% downside

Halyard Health (NYSE:HYH) Consensus Price Target History

Price Target History for Halyard Health (NYSE:HYH)

Halyard Health (NYSE:HYH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/3/2018Morgan StanleyBoost Price TargetUnderweight ➝ Underweight$48.50 ➝ $52.00HighView Rating Details
5/3/2018Deutsche BankBoost Price TargetBuy ➝ Buy$42.00 ➝ $50.00HighView Rating Details
5/3/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$52.00 ➝ $58.00LowView Rating Details
5/3/2018KeyCorpBoost Price TargetOverweight ➝ Overweight$61.00 ➝ $62.00LowView Rating Details
8/3/2017StephensUpgradeEqual Weight ➝ OverweightMediumView Rating Details
1/6/2017JMP SecuritiesDowngradeOutperform ➝ Market Perform$38.00N/AView Rating Details
(Data available from 5/24/2016 forward)

Earnings

Halyard Health (NYSE:HYH) Earnings History and Estimates Chart

Earnings by Quarter for Halyard Health (NYSE:HYH)

Halyard Health (NYSE:HYH) Earnings Estimates

2018 EPS Consensus Estimate: $0.92
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.07)($0.07)($0.07)
Q2 20181$0.40$0.40$0.40
Q3 20181$0.28$0.28$0.28
Q4 20181$0.31$0.31$0.31

Halyard Health (NYSE HYH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2018Q1 2018$0.17$0.76$155.08 million$156.40 millionViewN/AView Earnings Details
2/27/2018Q4 2017$0.50$0.73$413.94 million$428.10 millionViewN/AView Earnings Details
11/1/2017Q3 2017$0.47$0.60$394.54 million$401.40 millionViewN/AView Earnings Details
8/2/2017Q2 2017$0.37$0.51$399.16 million$399.20 millionViewListenView Earnings Details
5/2/2017Q1 2017$0.43$0.48$391.56 million$395.60 millionViewListenView Earnings Details
2/27/2017Q416$0.44$0.50$401.72 million$410.00 millionViewListenView Earnings Details
11/2/2016Q316$0.39$0.48$387.64 million$398.00 millionViewN/AView Earnings Details
8/3/2016Q216$0.36$0.45$383.08 million$400.00 millionViewN/AView Earnings Details
5/4/2016Q116$0.34$0.53$369.80 million$385.00 millionViewN/AView Earnings Details
2/29/2016Q415$0.50$0.57$401.96 million$401.40 millionViewListenView Earnings Details
11/3/2015Q315$0.47$0.52$388.00 million$390.00 millionViewN/AView Earnings Details
8/4/2015Q215$0.53$0.52$401.70 million$389.30 millionViewN/AView Earnings Details
5/4/2015Q1 2015$0.64$0.51$390.00 million$394.00 millionViewN/AView Earnings Details
3/4/2015Q4$0.75$1.59$425.10 million$439.40 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Halyard Health (NYSE:HYH) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Halyard Health (NYSE HYH) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.44%
Institutional Ownership Percentage: 90.51%
Insider Trading History for Halyard Health (NYSE:HYH)
Institutional Ownership by Quarter for Halyard Health (NYSE:HYH)

Halyard Health (NYSE HYH) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/4/2015Robert E AbernathyCEOBuy10,000$31.06$310,600.0080,043View SEC Filing  
9/1/2015Steven E VoskuilCFOBuy1,000$30.00$30,000.0028,729View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Halyard Health (NYSE HYH) News Headlines

Source:
DateHeadline
Analyzing Halyard Health (HYH) and ConforMIS (CFMS)Analyzing Halyard Health (HYH) and ConforMIS (CFMS)
www.americanbankingnews.com - May 22 at 1:18 AM
STERIS (STE) vs. Halyard Health (HYH) Head to Head ContrastSTERIS (STE) vs. Halyard Health (HYH) Head to Head Contrast
www.americanbankingnews.com - May 17 at 9:17 PM
$156.59 Million in Sales Expected for Halyard Health (HYH) This Quarter$156.59 Million in Sales Expected for Halyard Health (HYH) This Quarter
www.americanbankingnews.com - May 16 at 1:58 AM
Analysis: Positioning to Benefit within G-III Apparel Group, LTD, Diebold Nixdorf, Endologix, MACOMAnalysis: Positioning to Benefit within G-III Apparel Group, LTD, Diebold Nixdorf, Endologix, MACOM
www.nasdaq.com - May 15 at 8:47 AM
Analysis: Positioning to Benefit within G-III Apparel Group, LTD, Diebold Nixdorf, Endologix, MACOM Technology Solutions, Halyard Health, and REV Group — Research Highlights Growth, Revenue, and Consolidated ResultsAnalysis: Positioning to Benefit within G-III Apparel Group, LTD, Diebold Nixdorf, Endologix, MACOM Technology Solutions, Halyard Health, and REV Group — Research Highlights Growth, Revenue, and Consolidated Results
finance.yahoo.com - May 15 at 8:47 AM
Zacks: Analysts Anticipate Halyard Health (HYH) to Announce $0.38 EPSZacks: Analysts Anticipate Halyard Health (HYH) to Announce $0.38 EPS
www.americanbankingnews.com - May 14 at 9:10 PM
Halyard Health (HYH) Given Average Rating of "Buy" by AnalystsHalyard Health (HYH) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - May 14 at 7:22 PM
KeyCorp Weighs in on Halyard Healths Q2 2018 Earnings (HYH)KeyCorp Weighs in on Halyard Health's Q2 2018 Earnings (HYH)
www.americanbankingnews.com - May 7 at 2:08 AM
Halyard Health (HYH) Raised to "Hold" at Zacks Investment ResearchHalyard Health (HYH) Raised to "Hold" at Zacks Investment Research
www.americanbankingnews.com - May 4 at 3:34 PM
Q3 2018 Earnings Estimate for Halyard Health (HYH) Issued By KeyCorpQ3 2018 Earnings Estimate for Halyard Health (HYH) Issued By KeyCorp
www.americanbankingnews.com - May 4 at 7:42 AM
Halyard Health (HYH) PT Raised to $50.00 at Deutsche BankHalyard Health (HYH) PT Raised to $50.00 at Deutsche Bank
www.americanbankingnews.com - May 3 at 11:02 PM
Halyard Health (HYH) PT Raised to $52.00 at Morgan StanleyHalyard Health (HYH) PT Raised to $52.00 at Morgan Stanley
www.americanbankingnews.com - May 3 at 11:02 PM
Halyard Health (HYH) PT Raised to $58.00Halyard Health (HYH) PT Raised to $58.00
www.americanbankingnews.com - May 3 at 8:35 PM
KeyCorp Reaffirms Buy Rating for Halyard Health (HYH)KeyCorp Reaffirms Buy Rating for Halyard Health (HYH)
www.americanbankingnews.com - May 3 at 6:46 PM
Edited Transcript of HYH earnings conference call or presentation 2-May-18 1:00pm GMTEdited Transcript of HYH earnings conference call or presentation 2-May-18 1:00pm GMT
finance.yahoo.com - May 3 at 8:29 AM
Halyard Health (HYH) Announces  Earnings Results, Beats Estimates By $0.59 EPSHalyard Health (HYH) Announces Earnings Results, Beats Estimates By $0.59 EPS
www.americanbankingnews.com - May 2 at 1:56 PM
Halyard Health (HYH) Issues FY18 Earnings GuidanceHalyard Health (HYH) Issues FY18 Earnings Guidance
www.americanbankingnews.com - May 2 at 9:33 AM
Halyard Health beats by $0.59, beats on revenueHalyard Health beats by $0.59, beats on revenue
seekingalpha.com - May 2 at 8:34 AM
Halyard: 1Q Earnings SnapshotHalyard: 1Q Earnings Snapshot
finance.yahoo.com - May 2 at 8:34 AM
Halyard Health, Inc. Announces First Quarter 2018 ResultsHalyard Health, Inc. Announces First Quarter 2018 Results
finance.yahoo.com - May 2 at 8:34 AM
Analyzing ConforMIS (CFMS) and Halyard Health (HYH)Analyzing ConforMIS (CFMS) and Halyard Health (HYH)
www.americanbankingnews.com - May 2 at 3:20 AM
Halyard Health, Inc. Completes Divestiture of its S&IP BusinessHalyard Health, Inc. Completes Divestiture of its S&IP Business
finance.yahoo.com - May 1 at 8:38 AM
Halyard Health, Inc. to Present at the Deutsche Bank Health Care ConferenceHalyard Health, Inc. to Present at the Deutsche Bank Health Care Conference
finance.yahoo.com - May 1 at 8:38 AM
Analysts Expect Breakeven For Halyard Health Inc (NYSE:HYH)Analysts Expect Breakeven For Halyard Health Inc (NYSE:HYH)
finance.yahoo.com - April 30 at 5:04 PM
Zacks: Brokerages Expect Halyard Health (HYH) Will Announce Quarterly Sales of $153.20 MillionZacks: Brokerages Expect Halyard Health (HYH) Will Announce Quarterly Sales of $153.20 Million
www.americanbankingnews.com - April 29 at 4:04 AM
Contrasting Mine Safety Appliances (MSA) & Halyard Health (HYH)Contrasting Mine Safety Appliances (MSA) & Halyard Health (HYH)
www.americanbankingnews.com - April 27 at 7:04 PM
 Brokerages Anticipate Halyard Health (HYH) Will Post Earnings of -$0.04 Per Share Brokerages Anticipate Halyard Health (HYH) Will Post Earnings of -$0.04 Per Share
www.americanbankingnews.com - April 27 at 10:08 AM
Halyard Health, Inc. To Webcast Conference Call Discussing First Quarter 2018 Financial ResultsHalyard Health, Inc. To Webcast Conference Call Discussing First Quarter 2018 Financial Results
finance.yahoo.com - April 24 at 8:30 AM
Halyard Health (HYH) to Release Earnings on MondayHalyard Health (HYH) to Release Earnings on Monday
www.americanbankingnews.com - April 23 at 8:44 AM
Halyard Health (HYH) Given Consensus Recommendation of "Buy" by BrokeragesHalyard Health (HYH) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - April 19 at 7:21 PM
Halyard Health (HYH) Upgraded by Zacks Investment Research to "Buy"Halyard Health (HYH) Upgraded by Zacks Investment Research to "Buy"
www.americanbankingnews.com - April 18 at 11:54 PM
Owens & Minor Medical, Inc. -- Moodys downgrades Owens & Minors CFR to B1; outlook stableOwens & Minor Medical, Inc. -- Moody's downgrades Owens & Minor's CFR to B1; outlook stable
finance.yahoo.com - April 18 at 8:30 AM
Halyard Health (HYH) Rating Increased to Strong-Buy at ValuEngineHalyard Health (HYH) Rating Increased to Strong-Buy at ValuEngine
www.americanbankingnews.com - April 13 at 11:10 PM
Stephens Upgrades Halyard Health (HYH) to "Overweight"Stephens Upgrades Halyard Health (HYH) to "Overweight"
www.americanbankingnews.com - April 13 at 6:39 PM
Deutsche Bank Increases Halyard Health (HYH) Price Target to $42.00Deutsche Bank Increases Halyard Health (HYH) Price Target to $42.00
www.americanbankingnews.com - April 13 at 3:16 PM
$153.20 Million in Sales Expected for Halyard Health Inc (HYH) This Quarter$153.20 Million in Sales Expected for Halyard Health Inc (HYH) This Quarter
www.americanbankingnews.com - April 12 at 3:54 AM
Comparing Halyard Health (HYH) & Coloplast A/S (CLPBY)Comparing Halyard Health (HYH) & Coloplast A/S (CLPBY)
www.americanbankingnews.com - April 11 at 9:20 PM
-$0.04 EPS Expected for Halyard Health Inc (HYH) This Quarter-$0.04 EPS Expected for Halyard Health Inc (HYH) This Quarter
www.americanbankingnews.com - April 10 at 9:10 AM
24 Georgia CEOs earned more than 100X their employees' median pay in 201724 Georgia CEOs earned more than 100X their employees' median pay in 2017
finance.yahoo.com - April 9 at 8:40 AM
Halyard Health (HYH) Rating Lowered to Sell at Zacks Investment ResearchHalyard Health (HYH) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - April 7 at 11:36 PM
Halyard Health (HYH) Stock Rating Lowered by Zacks Investment ResearchHalyard Health (HYH) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - April 7 at 7:46 PM
Joe WoodyJoe Woody
www.benzinga.com - April 7 at 8:45 AM
Trump meets his match: Stormy Daniels combative lawyer Michael AvenattiTrump meets his match: Stormy Daniels' combative lawyer Michael Avenatti
www.latimes.com - April 7 at 8:45 AM
Benzingas Top Analyst Calls From April 6, 2018Benzinga's Top Analyst Calls From April 6, 2018
finance.yahoo.com - April 7 at 8:45 AM
Halyard Health (HYH) Earns "Hold" Rating from KeyCorpHalyard Health (HYH) Earns "Hold" Rating from KeyCorp
www.americanbankingnews.com - April 6 at 9:16 PM
Halyard Health Has 34% Upside Potential, KeyBanc Says In UpgradeHalyard Health Has 34% Upside Potential, KeyBanc Says In Upgrade
finance.yahoo.com - April 6 at 5:28 PM
Halyard Health (HYH) Rating Increased to Overweight at KeyCorpHalyard Health (HYH) Rating Increased to Overweight at KeyCorp
www.americanbankingnews.com - April 5 at 9:36 PM
Halyard Health (HYH) Downgraded by TheStreetHalyard Health (HYH) Downgraded by TheStreet
www.americanbankingnews.com - April 2 at 3:16 PM
Halyard Health, Inc. Appoints Sarker as Senior Vice President, InternationalHalyard Health, Inc. Appoints Sarker as Senior Vice President, International
finance.yahoo.com - April 2 at 8:58 AM
 Brokerages Anticipate Halyard Health Inc (HYH) Will Post Quarterly Sales of $153.20 Million Brokerages Anticipate Halyard Health Inc (HYH) Will Post Quarterly Sales of $153.20 Million
www.americanbankingnews.com - March 26 at 7:02 AM

SEC Filings

Halyard Health (NYSE:HYH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Halyard Health (NYSE:HYH) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Halyard Health (NYSE HYH) Stock Chart for Thursday, May, 24, 2018

Loading chart…

This page was last updated on 5/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.